Mukka Proteins Files SEBI Compliance Certificate for Q1 FY27
Mukka Proteins Limited submitted a certificate for the quarter ended June 30, 2026, as per SEBI regulations. The RTA confirmed no demat requests were processed as shares are not in physical form.
This is a standard compliance filing and does not introduce any new information or changes that would significantly affect the company's operations or market standing.
The announcement is a routine regulatory filing and does not contain any material information that would positively or negatively impact the company's stock.
Mukka Proteins Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. The Registrar and Share Transfer Agent, Cameo Corporate Services Limited, confirmed that no dematerialization requests were processed during this period as the company's shares are not held in physical form.
This filing is a routine compliance requirement for listed entities, ensuring adherence to SEBI regulations regarding the dematerialization of securities. The certificate covers the period from April 1, 2026, to June 30, 2026.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.